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Comparative Study of Pituitary-Thyroid Hormone Economy in
Fasting and Hypothyroid Rats
Donald L. St. Germain and Valerie Anne Galton
Departments of Medicine and Physiology, Dartmouth Medical School, Hanover, New Hampshire 03756

Abstract

Introduction

Starvation in laboratory rodents results in significant alterations
in thyroid hormone economy characterized by decreased circulating levels of thyroxine (T4) and 3,5,3'-triiodothyronine
(T3) and a decline in serum thyrotropin (TSH) concentration.
To investigate this apparent paradox, we have compared in
fasted and hypothyroid animals the intracellular parameters
mediating thyroid hormone action in the anterior pituitary
gland. In vitro saturation analysis combined with quantitation
of nuclear T3 content by radioimmunoassay allowed for characterization of pituitary nuclear T3 receptors and estimation of
the endogenous fractional receptor occupancy. In rats, thyroidectomized 4 wk earlier, the 10-fold increase in serum TSH
levels and decline in peripheral thyroid hormone concentrations
were accompanied by a 61% decrease in pituitary nuclear T3
content and a marked decline in fractional T3 receptor occupancy
as compared with control animals. In euthyroid animals subjected to short-term starvation (72 h), serum T3, T4, and TSH
levels declined by 52, 43, and 48%, respectively. Despite these
marked decreases in circulating thyroid hormone levels, pituitary nuclear T3 content in fasted rats declined by only 15%
(P < 0.05) relative to control levels. This modest decline in
nuclear T3 content, combined with a 23% decrease in total T3
receptor number, resulted in an estimated fractional receptor
occupancy in fasted animals which was equal to or greater
than that noted in controls. The effects of fasting and hypothyroidism on the pituitary were further investigated by quantifying
low Michaelis constant (Ki) T4 5'-deiodinase activity in the
crude cytosol fraction of pituitary homogenates. In thyroidectomized animals, maximum velocity was increased ninefold,
whereas fasting resulted in a 37% decrease (P < 0.025) in this
parameter compared with controls. K. values were similar in
all experimental groups (4.7±0.6 nM).
These results demonstrate that, despite significant reductions
in circulating thyroid hormone concentrations and pituitary T4
5'-deiodinase activity, nuclear T3 levels are maintained at
relatively normal levels in the pituitary of the fasted animal
and fractional T3 receptor occupancy may actually increase.
These findings are in marked contrast to those noted in
thyroidectomized animals and suggest that the suppression of
TSH secretion accompanying starvation in the rat is mediated,
at least in part, by local pituitary mechanisms that serve to
maintain and possibly enhance nuclear T3 receptor occupancy.

In both humans and laboratory animals, nutritional status
profoundly affects thyroid hormone economy and pituitary
function (1-4). In humans, shdrt-term starvation is accompanied by significant decreases in, serum total and free
3,5,3'-triiodothyronine (T3)' levels whereas thyroxine (T4) levels
are unaltered or slightly elevated (1, 3, 5, 6). In rodents, a 4872-h fast results in marked depressions of both free and total
T3 and T4 serum levels (7, 8). Evidence now suggests that
these lowered peripheral thyroid hormone levels have a proteinsparing effect and thus may be of considerable adaptive value
(6, 9-12).
The hypothalamic-pituitary axis appears to play an important role in maintaining the apparent thyroid hormonedeficient status of fasting animals. Thus, despite decreased
peripheral thyroid hormone levels, serum thyrotropin (TSH)
levels do not rise (1, 3, 5, 6). Indeed, in the rat, inanition
results in decreased serum and intrapituitary TSH levels and
eventual thyroid gland atrophy (2, 7, 13). The pituitary,
however, remains sensitive to thyroid hormone feedback (6,
14, 15) and the diurnal rhythm of TSH secretion is unchanged
(16) suggesting an altered "set-point" for TSH regulation in
the starving animal.
The physiologic mechanisms responsible for these adaptive
changes in pituitary function are uncertain, but they could
result from alterations in the secretion of hypothalamic hormones or be mediated by direct effects of nutritional deprivation
as noted in the liver (17). Alternatively, fasting could induce
changes in thyroid hormone economy in the pituitary. Only
limited data are available, however, concerning the effects of
starvation on the pituitary cellular mechanisms that influence
thyroid hormone action. Based on the results of a single
experiment using in vivo saturation techniques, Bavli (18) has
suggested that pituitary nuclear T3 receptor levels are decreased
in fasting rats. Others have reported that pituitary T4 5'deiodinase activity is unchanged (19, 20) or decreased (21, 22)
with starvation. How these alterations relate to fasting-induced
changes in pituitary function is uncertain.
In the present study, we have utilized in vitro techniques
to examine and compare in the rat the effects of short-term
starvation and hypothyroidism on pituitary nuclear T3 receptor
levels, nuclear T3 content, and the kinetics of T4 5'-deiodination.
Our results demonstrate marked differences in pituitary-thyroid
hormone economy in these two conditions. These differences
may have important implications in the control of pituitary
function and TSH secretion.

Portions of these studies were presented at the 65th annual meeting of
the Endocrine Society, June 1983, at San Antonio, Texas.
Received for publication 19 October 1983 and in revised form 25
October 1984.
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1. Abbreviations used in this paper: DTT, dithiothreitol; MBC, maxibinding capacity; NSB, nonspecific binding; T3, 3,5,3'-triiodothyronine; T4, thyroxine; TSH, thyrotropin.
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Methods
Male Sprague-Dawley rats were obtained from Charles River Breeding
Laboratories, Inc. (Wilmington, MA) and were kept under conditions
of controlled lighting and temperature. Fasting experiments (protocol
I) were conducted with 8-wk-old animals that had initial weights of
200-225 g. Before killing, animals were fasted for a 72-h period during
which time they were allowed free access to water and housed
individually in metal cages with wire-mesh floors to prevent coprophagia.
Control animals were maintained in a similar manner but were allowed
free access to pelleted rat diet. For experiments involving hypothyroid
and T4-injected animals (protocol II), normal and thyroidectomized
rats (7 wk old, 175-200 g in initial body wt) were purchased from the
same supplier. Animals were housed in pairs in clear plastic cages with
wood shavings for bedding and were given free access to food and
water. Thyroidectomized animals were given drinking water containing
calcium lactate (0.9 g/dl). Animals were killed 4-5 wk postsurgery.
T4-treated animals received 30 Mg of T4/100 g of body wt injected
subcutaneously for 18 d before killing and were utilized 24 h after the
last injection.
Tissue preparation. Animals were stunned and decapitated, and
trunk blood was collected. Anterior pituitaries from 4 to 11 animals
in each experimental group were pooled, weighed, and homogenized
by hand in 30 vol (wt/vol) of ice-cold homogenate buffer (0.25 M
sucrose, 0.02 M Tris-HCl, pH 7.6,

1

mM MgCI2, 2 mM CaCI2, 0.1

mM dithiothreitol [DTT], 5% glycerol). Subsequent procedures were
carried out at 0-40C. The crude homogenate was centrifuged at 800 g
for 10 min, and the supernate (designated cytosol hereafter for convenience) was used immediately for determination of T4 5'-deiodinase
activity as described below. The pellet was utilized to prepare a purified
suspension of isolated nuclei (verified by Nomarski interferencecontrast techniques) by modification of the method of Spindler et al.
(23). The pellet was washed twice with 2.5 ml of homogenate buffer
containing 0.5% Triton X-100, and then washed once and resuspended
in incubation buffer (0.25 M sucrose, 0.02 M Tris-HCI, pH 7.6, 1 mM
MgCl2, 0.1 mM DTT, 2 mM EDTA, 50 mM NaCl, 5% glycerol) using
a Dounce glass homogenizer. Aliquots of the nuclear suspension were
then utilized in T3 saturation studies. -60% of the DNA in the crude
homogenate (as determined by the method of Burton [24]) was
recovered in the purified nuclear preparation.
Characterization of nuclear T3 binding sites. Aliquots of the nuclear
suspension containing 15-35 Mg DNA were incubated in a total volume
of 1 ml of incubation buffer containing 4 X 10-" M '251-T3 (sp act
1,200 MCi/ug, New England Nuclear, Boston, MA) and stable T3
(Sigma Chemical Co., St. Louis, MO) sufficient to yield total concentrations of 5 X 10-" to 5 X lO-' M. Nonspecific binding (NSB) of
'25I-T3 was determined in all experiments by incubating nuclei with 1
or 5 X IO-' M stable T3. Incubations were performed at 22°C or 37°C
for varying periods of time. After incubation, nuclei were chilled to 04°C and centrifuged at 1,200 g for 10 min, and a 0.5-ml aliquot of
supernate removed for determination of free hormone concentration
by absorption on dextran-coated charcoal (25). Greater than 94% of
the total hormone in the supernate was in the free form. The nuclear
pellet was washed once with an ice-cold solution of 0.5% Triton X100 (in 0.25 M sucrose, 0.02 M Tris-HCI, pH 7.6, 1 mM MgCI2, 0.1
mM DTT, 5% glycerol), resuspended in 0.5 ml of homogenate buffer,
and counted in an automatic gamma counter (model 1195, Amersham/
Searle, Arlington Heights, IL). The suspension was then stored at
-20°C for subsequent DNA analysis. The single Triton X-100 wash
reduced NSB of '23I-T3 to <6% of total binding. Scatchard analysis
(26) of the binding data was carried out graphically (27). Points
represent single determinations.
Several experiments (each performed at least twice) were undertaken
to determine the optimal conditions for saturation analysis. (a) The
time course of in vitro association of T3 to isolated pituitary nuclei
was determined by incubating aliquots of nuclei from euthyroid
animals with 10-' M '23I-T3 for varying lengths of time and then
quantitating the amount of bound '25I-T3. (b) The rate of dissociation
-
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after in vitro labeling was measured by adding 5 X 10' M stable T3
to aliquots of nuclei previously incubated with 10-10 M '25I-T3 and
determining the time course of disappearance of radioactivity from the
nuclear pellet. (c) To determine the rate of in vitro dissociation of
endogenously bound T3, euthyroid rats were injected intravenously
with a "tracer" amount of 1251-T3 (4 ng/100 g body wt in phosphatebuffered saline containing 10% normal rat serum) 60 min before
killing. Pituitary nuclei were then isolated and incubated with 101 M
stable T3. At varying time intervals the nuclei were chilled to 0-40C,
and bound '251I-T3 was determined as described above. The rate of
dissociation was estimated by determining the time course of both 1251I
T3 disappearance from the nuclear pellet and '25I-T3 appearance in the
incubation medium. NSB was assessed in a second group of euthyroid
rats by the simultaneous injection of 20 gg of stable T3/100 g of body
wt with the 1251-T3. NSB was 3% of total '251-T3 binding. (d) To assess
further the effects of incubation conditions on the saturation analyses,
euthyroid rats were injected intravenously with sufficient stable T3 to
saturate the nuclear receptor sites completely (25 Mg of T3/100 g of
body wt). Animals were killed 90 min later, pituitary nuclei were
prepared, and saturation studies were performed under various conditions of time and temperature. Euthyroid animals injected with an
equivalent volume of vehicle served as controls.

Determination ofnuclear T3 content. The amount of T3 present in
pituitary nuclei was determined by radioimmunoassay (RIA) according
to the methods of Larsen et al. (28). Individual rat anterior pituitary
glands were homogenized by hand in I ml of homogenate buffer.
Isolated pituitary nuclei were prepared as described above and extracted
twice with 0.5 ml of absolute ethanol at 370C for 30 min. The nuclear
pellet was then stored at -20°C for subsequent DNA analysis. The
two extracts for a given sample were pooled and stored at -20°C for
subsequent T3 RIA. Extraction efficiency was determined by injecting
euthyroid rats intravenously with "tracer" amounts of '251-T3 (4 ng/
100 g body wt) 60 min before killing. Recovery of '25I-T3 in the nuclear
extract was 84.3 ± 1 .8%in the first ethanol extract and 96.7 ± 2.5%after
two extractions. NSB of '25I-T3 was 3% as noted earlier, thus no
correction for extraction efficiency or NSB was applied.
Determination of T4 5'-deiodinase activity. T4 5'-deiodinase activity
was determined in the cytosol fraction of the crude pituitary homogenate
by modification of the methods of Kaplan (21). T4 was obtained from
Henning, Co. (Berlin, Federal Republic of Germany) and contained
<0.1% T3 by the manufacturer's specifications. Aliqtuots (190 Ml) of
cytosol enriched with DTT to a final concentration of 20 mM were
preincubated at 37°C for 10 min in stoppered plastic vessels. T4 was
then added as a 10-,Iu aliquot in 0.25 M sucrose, 0.05 M Tris-HCI, pH
7.6, to yield a final concentration of 1.4-100 nM. Duplicate 40-MA
samples of reaction mixture were then immediately removed for zero
time samples and each mixed with 80 Ml of ice-cold 95% ethanol.
Incubation was then carried out for 10-30 min at 37°C after which
duplicate samples were again obtained. After storage at 4°C for 24-36
h, ethanol extracts were centrifuged at 12,000 g and the supernate
fraction stored at -200C until assayed for T3 by RIA. Recovery of T3
by ethanol extraction of the reaction mixture was >96%. Protein was
determined on aliquots of cytosol before enrichment with DTT by the
method of Lowry et al. (29). Kinetic data were analyzed by EadieHofstee plots (30).
RIA methods. T3 concentrations in ethanol extracts and serum
were determined by RIA by modification of the procedures of Larsen
et al. (28, 31). A 5-d, nonequilibrium assay method with a combined
polyethylene-glycol/second antibody separation step was employed.
For cytosolic ethanol extracts from T4 5'-deiodinase experiments, the
assay buffer consisted of 0.2 M glycine, 0.13 M sodium acetate, pH
8.6, with 20 mg/dl bovine serum albumin. Extract aliqiuots (10 Ml)
were assayed directly and equivalent volumes of ethanol/homogenate
buffer were added to the standard curve. Specifically-bound '25I-T3 in
the "zero" binding tubes ranged from 25 to 35%. NSB in the standard
tubes was <2.0%. In sample tubes NSB was 2-4% And was determined
for representative samples in all assays. Assay sensitivity, defined as
the dose of T3 resulting in '25I-T3 displacement from antibody greater

than three standard deviations from the zero binding, varied from 0.2
to 0.6 pg/tube. The amount of T3 resulting in 50% displacement of
tracer from zero binding was 3-6 pg/tube. Logit-log plots of the
standard curve were linear from 0.2 to 30 pg/tube. Intra- and interassay
coefficients of variation were 6% and 9%, respectively, at 3 pg of T3/
tube.
Before assay, nuclear ethanol extracts were dryed under N2 at 370C
and then reconstituted in 100 1l of 0.1 N NaOH, 565 Al RIA assay
buffer, and 35 Ad of human serum previously treated with an ion
exchange resin (32). Recovery of T3 from the dried sample was >99%.
Duplicate 200-Al aliquots of this mixture were then assayed for T3
content with a third aliquot used to determine NSB. For these assays
10 1l of resin-treated human serum was added to the standard curve
and 2.74 g/dl sodium salicylate was included in the assay buffer. Assay
sensitivity was 0.4-1.0 pg of T3/tube with 50% displacement of tracer
occurring with 6-10 pg of T3/tube. Dilutions of nuclear extracts over
an eightfold range were parallel to the standard curve. The T3 content
of nuclear extracts from control, fasting, and hypothyroid animals as
determined by RIA with our standard separation step was compared
with values obtained with a charcoal separation step optimized according
to the methods of Odell (33). The coefficient of variation for five
samples determined by the two techniques was <5%.
For determining serum T3 and T4 concentrations, 1 g/dl sodium
salicylate was included in the assay buffer (31). Sample size was 10 AI
of serum in the T3 RIA and 2 Al in the T4 RIA and an equivalent
volume of thyroid hormone depleted rat serum (32) was added to the
standard curves. Assay sensitivity was - 1 pg of T3/tube and 5 pg of
T4/tube.
TSH was assayed using materials kindly supplied by the National
Institute of Arthritis, Digestive and Kidney Diseases by Dr. A. Parlow.
Results are expressed in terms of the rat TSH RP- 1 standard.
All results are given as mean ± standard error (SE). Data were
analyzed using the t test for paired and unpaired values and twovariable linear regression analysis.

Table I. Serum T3, T4, and TSH Levels*
T3

T4

TSH

ng/dl

Ag/dl

ng/ml

Protocol I
Control (15)
Fasting (15)
Protocol II
Control (13)
Hypothyroid (14)
T4-injected (9)

77±5

6.0±0.3

37±4t

3.4±0.3t

282±40
147±24§

49±3

5.2±0.2

449±57

23±2t
131±18t

0.6±0.1t

4490±318t
76±21 t

17.7±4.2"

* The data are presented as the mean±SE. (n)
group.
t P < 0.001 compared with control.
§ P < 0.01 compared with control.
"P < 0.02 compared with control.

=

number of rats per

dissociation of bound '251-T3. After 3.5 h only 30% was dissociated. A comparably slow rate of dissociation (25% at 3.5
h) was noted in vitro at 220C when pituitary nuclei were
labeled in vivo with "tracer" amounts of '251-T3. With prolonged
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Animals fasted for 72 h lost an average of 22% of their initial
body weight compared with an 11% increase in weight of
control animals. In addition, pituitary wet weight was 21%
lower in fasted rats (7.3 ± 0.1 mg/pituitary control vs. 5.8 ± 0.1
mg/pituitary fasting, P < 0.001) and total pituitary cytosolic
protein content was decreased by 13% (P < 0.1). The ratio of
cytosolic protein to DNA content, however, was similar in
control, fasting, and hypothyroid animals (mean value: 13.8 ± 0.8
mg of cytosolic protein/mg of DNA).
Serum T3, T4, TSH levels. Serum total T3, T4, and TSH
levels for animals from the two experimental protocols are
shown in Table I. In fasted animals (protocol I), serum T3 and
T4 levels were decreased to 48 and 57% of control values,
respectively. Fasting also resulted in a 48% reduction in serum
TSH levels. In experiments involving hypothyroid and T4injected animals (protocol II), serum T3 and T4 levels were
lower in control rats than in the protocol I control animals
(T3 P < 0.001, T4 P < 0.025) whereas TSH levels were higher
(P < 0.05). In thyroidectomized animals serum T3 and T4
levels were decreased to 47 and 12% of control values whereas
TSH levels were increased 10-fold. In rats receiving T4 injections, both serum levels of T3 and T4 were elevated approximately threefold whereas TSH levels were decreased by 83%.
Technical aspects of saturation analysis. The kinetics of
'25I-T3 binding to isolated pituitary nuclei from euthyroid rats
was investigated at both 22 and 37°C. At 22°C (Fig. 1 A),
maximal binding occurred between 10 and 20 h of incubation
and then declined. Approximately 8 h was required for 50%
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Figure 1. Time course of in vitro association/dissociation of '25I-T3
with isolated pituitary nuclei from euthyroid rats. Anterior pituitary
glands from 22 male rats (200-225 g) were pooled and a purified
suspension of nuclei was prepared as described. Aliquots of the
suspension were then incubated for varying periods of time with
10-1o M 12511-T3 at either (A) 220C or (B) 370C. At the times
indicated by the arrows, stable T3 (final concentration 5 x 10-' M)
was added to some of the incubation tubes. NSB at both incubation
temperatures was assessed by incubating aliquots of the nuclear suspension beginning at time zero with both '251I-T3 and 5 x 10-7 M
stable T3. The data at 370C depicted in (B) are reproduced in (A) for
comparison.
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in vitro incubation (30-50 h), 80% of either the in vivo- or in
vitro-bound '25I-T3 dissociated. Binding kinetics at 370C were
considerably more rapid (Fig. 1 B); near-maximal binding was
achieved after 30 min of incubation and only 20 min was
required for 50% dissociation of bound hormone. Total binding
at 370C, however, was only 56% of that at 220C reflecting a
temperature-dependent decrease in receptor affinity as well as
probable greater receptor instability.
The slow dissociation rate at 220C indicated that saturation
studies carried out at this temperature for relatively brief
incubation periods (3.5 h) would primarily determine unoccupied receptor sites. To confirm this, saturation experiments
were performed in isolated pituitary nuclei from euthyroid
animals injected 90 min prior to killing with a large dose of
stable T3 (25 ,ug of T3/100 g of body wt). As shown in Fig. 2
A, Scatchard analysis after 3.5 h of incubation revealed a very
low, apparent maximum binding capacity (MBC) in the T3injected animals compared with vehicle-injected controls (MBC
0.2 vs. 1.4 pmol T3/mg DNA, respectively). More prolonged
periods of incubation (27 h) resulted in higher apparent MBC
values in nuclei from T3 injected animals (MBC 1.2 pmol T3/
mg DNA) demonstrating exchange of '25I-T3 with endogenously
bound hormone.
The possibility was considered that the low apparent MBC
at 3.5 h of incubation observed in T3-injected animals was
secondary to a high nuclear T3 content, contributing substantial
quantities of hormone to the in vitro saturation analysis. This
would result in higher total T3 concentrations and decreased
'251I-T3 binding. However, direct measurement of nuclear T3
by RIA revealed levels in T3-injected animals of -3 pmol T3/
mg DNA, an amount that would increase the total mass of T3
in the tubes containing the high concentrations of T3 by <10%
and thus not significantly affect the MBC. The substantial
increase in the apparent MBC at 27 h in T3-injected animals
provides a further argument against an artifactual lowering of
the MBC by this mechanism. In addition, the latter result
precludes the possibility that the low apparent MBC noted
after 3.5 h of incubation was due to a rapid decrease in receptor
number in vivo after the T3 injection.
Scatchard analysis of saturation experiments performed at
an incubation temperature of 37°C (Fig. 2 B) revealed a similar
MBC in nuclei from animals injected either with vehicle or
large doses of T3, confirming the rapid dissociation rate noted

in the kinetic experiments. However, despite complete dissociation of endogenous hormone at 37°C, the MBC of -I
pmol T3/mg DNA was not greater than that determined at
22°C. This implied a significant and relatively rapid loss of
receptor binding capacity at 37°C.
In contrast to the effects of prolonged incubation at 22°C
with nuclei from T3-injected animals, incubation of nuclei
from vehicle-injected or euthyroid control animals for periods
longer than 3.5 h did not significantly increase the MBC. As
shown in Fig. 3, the apparent MBC in euthyroid nuclei
increased from 0.98 to 1.15 pmol T3/mg DNA when in vitro
incubation was extended from 1 to 3.5 h at 22°C. This increase
in MBC of 0.17 pmol T3/mg DNA correlates well with a
predicted increase of 0.21 pmol T3/mg DNA given an endogenous nuclear T3 content of 1.4 pmol T3/mg DNA (discussed
later) and the fact that -15% of the endogenously bound
hormone should dissociate between 1 and 3.5 h of incubation.
With a stable binding system, extension of the incubation
period to 27 h should result in a further increase in the
apparent MBC to -2.0 pmol T3/mg DNA. Such an increase,
however, was not observed either in the experiment depicted
in Fig. 3 or in three additional experiments where the effects
of incubation time on MBC were investigated. Presumably
greater degrees of T3 binding were not observed with the more
prolonged incubation periods in euthyroid nuclei due to a
relative balance between the rates of endogenous hormone
dissociation and receptor degradation.
The results of the preceding experiments demonstrated
that in vitro saturation techniques under the conditions employed could not accurately quantify total T3 receptor capacity
in isolated pituitary nuclei. However, the MBC determined
from saturation studies carried out for relatively short incubation periods (3.5 h) at 22°C (MBC22') appeared to reflect
reliably the unoccupied receptor capacity. Because -25%
of endogenously bound hormone dissociates under these
conditions, the following relationship was used to estimate the
number of unoccupied receptor sites: unoccupied sites
= MBC22' - (0.25) occupied sites. Thus, the number of
unoccupied sites and, hence, total receptor capacity could be
estimated using data from the in vitro saturation studies
(MBC22.) and values obtained by RIA for nuclear T3 content.
Saturation studies at 22°C. Scatchard analysis of saturation
studies performed at 22°C for a 3.5-h incubation period with
-

B 370C

B/F

B/F

o
BOUND
(pmol T3/mg DNA)
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Figure 2. Scatchard analysis of in vitro binding
data to isolated pituitary nuclei from euthyroid
rats injected with a saturating dose of T3. (A)
Male rats (200-225 g) were injected intravenously 90 min before sacrifice with either 25
1Ag of stable T3/l00 g of body wt (15 animals)
on an equal volume of vehicle (eight animals).
Anterior pituitary glands from each group of
rats were pooled, a suspension of isolated nuclei was prepared, and saturation analysis was
performed at 22°C for either 3.5 or 27 h. (B)
Incubation at 37°C for 2 h. Free concentrations are expressed in nanomolar. ., T3 injected; o, vehicle injected.

B4
1h

10-

0

0.5

1.0

1.5

BOUND
(pmol T3/mg DNA)

Figure 3. Effects of varying incubation time at 220C on saturation
analysis in isolated nuclei from euthyroid rats. Anterior pituitary
glands from 32 male rats (200-225 g) were pooled, a suspension of
isolated nuclei was prepared, and saturation analysis was performed
at 220C for 1, 3.5, 10, or 27 h. Values of Kd for each preparation are:
6.5 X 10"- M (1 h), 4.7 X 10-1" M (3.5 h), 3.4 X 10-1" M (10 h),
and 3.9 X 10-" M (27 h). Free concentrations are expressed in
nanomolar.

pituitary nuclei from all experimental groups revealed a single
class of saturable, high-affinity binding sites. Representative
experiments are shown in Fig. 4. As summarized in Table II,
values of MBC22- obtained in control animals from protocol I
were somewhat lower than control values noted in protocol II
(P < 0.01). Fasting resulted in a 29% decrease in MBC22£, a
decrease similar to that noted in two groups of T4-injected
animals. In hypothyroid animals, MBC22- was increased by
42%. Values for the equilibrium dissociation constant (Kd)
(Table II) were similar for all groups with a mean value of
7.2 ±0.75X 10-" M (n = 18).
Nuclear T3 content and estimation of total nuclear receptor
capacity. Levels of receptor-bound endogenous T3 are shown
in Table II. The nuclear T3 content of control animals from
protocol I experiments was significantly higher than that noted
in the protocol II control group (P < 0.001); a finding consistent
with the higher serum T3 and T4 levels and lower TSH levels
seen in the former group. In fasted animals, nuclear T3 levels
were significantly decreased; however, the decrease was relatively
modest (- 15%) given the much larger decreases noted in
serum T3 (52%) and serum T4 (43%) levels. Thyroidectomized
animals demonstrated a 61% decrease in nuclear T3 content.
Because the MBC22- and nuclear T3 content data were
obtained in different groups of experimental animals, the mean

values of these parameters were utilized to calculate the
unoccupied and total receptor binding capacities. As shown in
Table II, these estimated values decreased 32 and 23%, respectively, during fasting. Although the nature of the experimental
data prevents a statistical analysis of these calculated figures,
the fact that they are derived from two experimental data sets,
each of which showed statistically significant decreases with
fasting, strongly suggests that these calculated values are also
of significance. Estimates of receptor occupancy revealed that
62% of binding sites were occupied in fasted animals compared
with a 56% occupancy rate in protocol I controls. The significance of this increase in T3 receptor occupancy accompanying
fasting can again only be inferred from the fact that the 29%
decrease in MBC22. in fasted rats was approximately twice the
decrease noted in nuclear T3 content. Thus the decrease in
unoccupied and total receptor sites was relatively greater than
the decrease in occupied sites suggesting an actual increase in
receptor occupancy.
In hypothyroid animals, the number of unoccupied nuclear
T3 binding sites was estimated to increase by -55% as
compared with protocol II controls. Total binding capacity
was also calculated to be slightly higher in hypothyroid animals
(2.7 vs. 2.3 pmol T3/mg DNA, respectively). The fact, however,
that nuclear T3 levels decreased and MBC22' increased by
comparable amounts in the thyroidectomized group (0.5 pmol
T3/mg DNA decrease in nuclear T3 vs. 0.7 pmol T3/mg DNA
increase in MBC22') suggests that total binding capacity is
unaltered in hypothyroidism. As expected from the marked
decrease in nuclear T3 content, receptor occupancy in hypothyroid animals was considerably lower than in control animals.
Although nuclear T3 content was not determined in T4-injected
animals, one can estimate that given the marked decrease in
MBC22- and assuming no change in total receptor number,
nuclear occupancy in this group of animals would be -70%.
Confirmation of these estimates of total receptor capacity
was sought by performing saturation analysis under such in
vitro conditions that would allow complete dissociation of
endogenous hormone (1-h incubation at 370C). In two experiments, fasting resulted in a 25% and 42% decrease in MBC.
These values provide additional evidence that the decrease in
total receptor capacity during fasting is relatively greater than
the decrease in nuclear T3 content and thus support the
previous estimates of an actual increase in receptor occupancy.
Similar experiments utilizing thyroidectomized animals demonstrated a 36% increase in MBC in one experiment and a
7% decrease in another, thus confirming that total receptor
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Figure 4. Scatchard analysis of in vitro binding data
to isolated pituitary nuclei from (A) control and fasting animals (protocol I) and (B) control, T4 injected,

2

1

BOUND
(pmol T3'mg DNA)

BOUND
(pmol T3 'mg D0 NA)

and thyroidectomized animals (protocol II). Anterior
pituitaries from 4 to 11 animals in each experimental
group were pooled, a suspension of isolated nuclei
was prepared, and saturation analysis was performed
at 22°C for 3.5 h of incubation. Free concentrations
are expressed in nanomolar.
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Table II. Results of Saturation Analysis at 220C, Nuclear T3 Content, and Estimation ofNuclear Receptor Capacity*
Saturation analysis

Protocol I
Control
Fasting
Protocol II
Control
Hypothyroid
T4-injected

Kd

MBC22.

Nuclear T3 content

Unoccupied
receptor capacity

Total receptor
capacity

X H)-" M

pmot T,/mg DNA

pmole T,/mg DNA

pmoj
T/mg DNA

pmote T3/mg DNA

7.1±1.1 (7)
8.0±2.0 (3)

1.48±0.04 (7)
1.05±0.08 (3)t

1.43±0.06 (8)
1.21±0.07 (7)§

1.11
0.75

2.54
1.96

56
62

6.5±0.8 (3)
4.4±0.5 (3)
7.1,15.0 (2)

1.73±0.05 (3)
2.45±0.17 (3)"
1.13,1.16 (2)

0.79±0.04 (13)
0.33±0.07 (6)t

1.53
2.37

2.32
2.70

34
12

Receptor
occupancy

* Data are presented as mean±SE. (n) = number of experiments for Kd and MBC22. and number of animals for nuclear T3 content.
Unoccupied receptor capacity calculated as MBC22. - (0.25) nuclear T3 content. Total receptor capacity calculated as nuclear T3 content
+ unoccupied receptor capacity. Receptor occupancy calculated as (nuclear T3 content . total receptor capacity) X 100. Mean values of MBC22.
and nuclear T3 content were used in these calculations. $ P < 0.005 compared with control. § P < 0.05 compared with control. Not included
in the nuclear T3 content data for fasting animals is the value in one animal, which was greater than 3 SD above the mean for the rest of the
fasting group and greater than any value determined in the control group. Inclusion of this animal alters the mean fasting value very little
(1.28± 1.0 pmol T3/mg DNA); however, statistical significance is lost (P = 0.2). 1"P < 0.02 compared with control.

number is either unchanged or somewhat increased in hypothyroid animals. The average value of the Kd determined by
Scatchard analysis in these experiments was twice the value
noted when saturation analysis was performed at 220C
(14.2±1.53 X 10-" M [n = 8] vs. 7.2±0.75 X 10-11 M [n
= 18] respectively, P < 0.001).
T4 S'-deiodinase activity. The time course of T4 5'-deiodination in the cytosol fraction of the homogenate from euthyroid
pituitaries is shown in Fig. 5. The reaction rate was linear for
the first 5 min of incubation and then slowly decreased. At
10, 14, and 30 min, the reaction rates were 90, 81, and 61%,
respectively, of the initial velocity noted at 5 min. Incubation
times utilized in subsequent experiments were 14-15 min in
control and fasted animals, 10 min in hypothyroid animals,
and 30 min in T4-injected animals. These times were designed
to minimize substrate utilization and yet allow for sufficient
T3 accumulation for accurate measurement by RIA. Correction
factors for these varying incubation times were not applied. In
other experiments, aliquots of cytosol kept at 0-40C maintained
>90% of activity for 1 h. The coefficient of variation of

replicate determinations at low substrate concentrations was
<15% and at high substrate concentrations <10%. The rate of
T3 formation was found to increase linearly with homogenate
protein concentration up to 6 mg/ml. Protein content of the
crude cytosolic preparation was typically 2-3 mg/ml. Incubation
of homogenates from both control and fasted animals with
known concentrations of stable T3 and 20 mM DTT for 30
min at 370C failed to disclose any evidence of T3 degradation.
No evidence of T3 formation was noted in cytosol fractions
that were either heated to 80'C for 45 min or were not
enriched with DTT.
Using substrate concentrations of 1.4-100 nM T4 and 20
mM DTT, 5'-deiodination of T4 displayed simple saturation
kinetics. Eadie-Hofstee plots (Fig. 6) revealed apparent Michaelis constant (Km) values of -4 nM in both control and
fasting animals, reflecting the low K. (type II) 5'-deiodinase
component responsible for the majority of T4 to T3 conversion

0.8-
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Figure 5. Time course of T3 formation from T4 5'-deiodination in the
cytosol fraction of euthyroid pituitary homogenates. Substrate concentrations were 9 nM T4 and 20 mM DTT. Points represent the
mean of duplicate determinations, which varied by <10%.
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Figure 6. Kinetic analysis of pituitary T4 5'-deiodinase activity in
control and fasting rats by use of the Eadie-Hofstee plot. Aliquots of
the pooled cytosol fraction from pituitary homogenates were incubated with 1.4-100 nM T4 and 20 mM DTT for 14-15 min. T3
formation was then quantified in ethanol extracts of the reaction
mixture by RIA. T4 concentrations are expressed in nanomolar.

in the pituitary (34). As shown in Table III, fasting was
associated with a 37% decrease (P < 0.025) in maximal enzyme
activity (Vmax). In hypothyroid animals, Vma, increased approximately ninefold, whereas in T4-injected animals, 5'-deiodinase activity was reduced to - 10% of the value seen in
control animals.

Discussion
The principal goal of the present study was to compare the
intracellular factors affecting thyroid hormone action in the
pituitary during the fasting and hypothyroid states. Because
the interaction of T3 with specific, high-affinity nuclear-binding
sites appears to represent an important event in the control of
TSH secretion (35-37), we sought to quantify pituitary T3generating activity and the number and degree of occupancy
of nuclear thyroid hormone receptors. The application of in
vitro receptor-binding techniques to isolated pituitary nuclei
was complicated significantly by receptor occupancy with
endogenous hormone, slow dissociation of the hormonereceptor complex at 220C, and receptor instability at both 22
and 370C. This combination of factors can obviously result in
serious misinterpretation of in vitro binding data. The attainment of a plateau in the association curve, as demonstrated
between 10 and 21 h at 220C and 30 and 90 min at 370C
(Fig. 1), is clearly insufficient evidence that both stability and
equilibrium conditions exist so that total receptor capacity can
be determined accurately by Scatchard analysis.
The justification for applying Scatchard analysis in these
experiments where nonsteady-state conditions exist is based
on the rapid attainment of equilibrium with the unoccupied
receptor fraction. As discussed by Aranyi (38) and Yeakley et
al. (39), lack of equilibrium with unoccupied binding sites
results primarily in underestimation of receptor affinity with
only minimal error in the determination of unoccupied binding
capacity. The high receptor affinity noted at 220C (Kd -7
X 10-" M), as well as the lack of significant change in the Kd
when incubation is extended from 3.5 to 27 h (Fig. 3), strongly
suggests that equilibrium with unoccupied receptor sites occurs
rapidly.
A somewhat surprising finding in this study was the
significant differences noted between protocol I and protocol
Table III. Pituitary T4 S'-Deiodinase Activity*

Protocol I
Control (4)
Fasting (5)
Protocol II
Control (3)
Hypothyroid (3)
T4-injected (2)t

Km

V.

nM

finol Tj/min * mg prot

4.3±0.5
4.0±0.4

5.2±1.2
7.0±1.8
-

95±11

60±6§
57±9

491±59"
7, 3

* Data are presented as mean±SE. (n) = number of experiments.
f Velocity values for T4-injected animals were determined at a single
T4 concentration of 100 nM. Enzyme activity was too low to permit
determination of Km_
§ P < 0.025 vs. control.
1 P < 0.005 vs. control.

II control groups in essentially all experimental parameters.
These differences were not due to interassay variation in that
values for the various serum parameters for all experimental
groups were determined in the same assays. In addition,
experimental values for control groups within a single protocol
were remarkably consistent as shown in Tables I-IlI. Although
experiments involving animals in protocols I and II were not
performed on the same day, experiments were frequently
carried out concurrently, and thus there was no significant
difference in the time frame of data acquisition. Of possible
importance, however, is the fact that protocol I control animals
were somewhat younger at the time of sacrifice than protocol
II controls (8 wk vs. 11 wk, respectively) and were housed
under potentially more stressful conditions (as discussed earlier).
These factors may have contributed to the differences observed
in the experimental data between the two groups.
Experimental findings and physiologic implications. Although thyroid hormones are of unquestionable importance
in controlling various pituitary functions, the cellular mechanisms mediating these effects remain poorly understood. Recent
evidence suggests that the regulatory effects of T3 on TSH
secretion may be related to the degree of occupancy of pituitary
nuclear T3 receptors (35-37). Our finding that hypothyroidism
is accompanied by a 61% decrease in nuclear T3 content and
a marked decrease in receptor occupancy is consistent with
this hypothesis and confirms work by previous investigators
(28, 40). In fasted rats, however, a strikingly different situation
is seen despite significant decreases in both serum T3 and T4
concentrations. Thus, although nuclear T3 levels in starved
animals are also decreased, the decrease is relatively modest
(15%) and when combined with the 23% reduction in total
binding capacity, receptor occupancy appears to be unchanged
or actually increased relative to control values. If indeed
receptor occupancy (irrespective of total receptor number) is
the key parameter mediating thyroid hormone regulation of
TSH secretion, then the present results offer a plausible
explanation for the failure of TSH levels to rise during shortterm fasting in the rat. Support for this concept can be
obtained from the present studies. For the five experimental
groups examined, an excellent correlation was noted between
the estimated receptor occupancy and the mean serum TSH
levels as shown in Fig. 7 (r = -0.97, P < 0.01). Although
other factors not specifically addressed in these studies, such
as alterations in hypothalamic secretion or postreceptor events
mediated directly by fasting, may also be important in the
response of the pituitary to starvation, the maintenance of
relatively normal nuclear T3 levels and normal to increased
receptor occupancy are likely to be important contributing
factors to the observed suppression in circulating TSH levels.
Our data regarding thyroid hormone economy in the
pituitary during fasting are in sharp contrast to the findings
reported by others in the liver (8). Thus, short-term starvation
in the rat is accompanied by profound decreases in hepatic
nuclear T3 levels which, despite a decrease in total receptor
number, result in a significantly decreased receptor occupancy
rate (8, 41, 42). Accompanying these observed changes are
metabolic alterations in the liver and other peripheral tissues
that appear to be due in part to decreased thyroid hormone
action (1, 6, 9-11, 17, 43). In this regard, the decrease in
hepatic T4 5'-deiodinase activity (high Ki type I) noted in
fasting (44) is similar to that occurring in hypothyroidism (22)
and can largely be reversed by the administration of thyroid
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Figure 7. Mean serum TSH concentrations plotted as a logarithmic
function of the estimated.T3 receptor occupancy for the five experimental groups. Receptor occupancy in T4-injected animals was calculated by assuming a total receptor number equal to that in protocol
II control animals. Control I, o; fasting, o; control II, *; hypothyroid,
A; T4-injected, .; r = -0.97, P <
0.01.

hormone during the fasting period (45, 46). In contrast, the
decreased pituitary T4 5'-aeiddinase activity (low K, type II)
noted in the present study is qualitatively similar to that seen
in the T4-injected animals (21)and thus suggests an enhanced
action of thyroid hormone on the hypophysis during fasting,
a formulatipn, that is consistent with the observed decreases in
serum TSH levels and the increases noted in nuclear receptor
occupancy.
The factors responsible for the maintenance of near normal
pituitary nuclear T3 levels in the fasted rat are uncertain but
of potentially great physiologic importance. Although in vivo
rates of T4' to T3 conversion were not determined in the
present study, one can infer, fiom the observed decreases in
serum T4 levels and in vitro 5':deiodinase activity that "local"
T3 generation bythe pituitary as a whole is diminished during
fasting. Mechahisms that could serve to "protect" nuclear T3
levels in the fastinig- state include an increase in the rate of
cellular or nuclear T3 entry, a decrease in the fractional rate
of cellular T3 degradation, or a decrease in the turnover rate
of occupied T3 receptors. Additional studieswill be required
to address thesepossibilities.
Coruparison withprior studies. A comparison of the present
data with previous studies reveals apparent discrepancies in
the values for T3 receptor number and occupancy. Others, by
using in vivo saturation techniques, have estimated that the
binding capacities ofeuthyroid and hypothyroid rat pituitary
nuclei are 1.2 and 1.5pmol T3/mg, DNA, respectively (18, 36,
47), values that are 50% lowver than those determined in the
present study. Similar discrepancies have been noted between
data obtained in vivo and in vitro in cerebral cortex (48).
Although the reasons for these differences are uncertain, several
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possibilities exist. Aig important assumption inherent to the in
vivo technique is that equilibration has been achieved between
serurh and nuclear T3 (49). Recent evidence, however, suggests
that the entry of T3 to both the cytoplasm and the nucleoplasm
may be a receptor-mediated, saturable process (50-52). Thus
significant intracellular free T3 gradients may exist (52) and
equilibration between serum, cytoplasm, and nucleus may be
delayed at the higher serum T3 levels employed during in vivo
saturation studies. Furthermore, given that the time for 50%
dissociation of the T3-receptor complex in vivo may be as
long as 1 h (53), it is unlikely that the rather brief period of
time during the in vivo analysis when serum and nuclear 1251
T3 levels are in steady state is sufficient for a true equilibrium
to occur with previously occupied receptors.'Given these
uncertainties, it is possible that the two-compartment model
(54), which forms the basis for the in vivo saturation techniques,
represents an oversimplification and results in the measurement
of only a fraction of the total complement of nuclear receptors.
Alternatively, it is possible that the procedures utilized herein
in preparing the nuclei for the in vitro studies expose additional
nuclear T3-binding sites not available for in vivo binding. This
appears unlikely, however, because in vivo injection of a large
dose of T3 reduced MBC22- to a very low value (Fig. 2 A),
indicating complete receptor saturation. Regardless of the
reasons for these differences, however, our finding of a significant number of unoccupied binding sites in hyperthyroid
animals (Table II) and a large discrepancy in apparent MBC
(after 3.5 h of incubation) in nuclei from vehicle-injected and
in vivo T3-saturated animals (Fig. 2 A) strongly suggests that
endogenous pituitary receptor occupancy in the euthyroid rat
is less than the 78% value reported by Silva et al. (55), who
used in vivo techniques.
The application of in vitro saturation techniques to pituitary
tissue has been limited (56). Recently, Coulombe et al. (57)
and von Overbeck and Lemarchand-Beraud (58) have reported
a significant decrease in the number of solubilized pituitary
nuclear T3 receptors in adult hypothyroid rats; an observation
that is in marked contrast to the present data and that noted
previQusly by Silva and Larsen (36), who used in vivo techniques
and by Samuels et al. (59) in T3-depleted growth hormone
(GHI) cells. Neither Coulombe et al. (57) or von Overbeck
and Lemarchand-Beraud (58), however, adequately address
the issues of receptor stability, association/dissociation rates,
establishment of equilibrium with endogenously occupied sites,
or efficiency of the receptor extraction technique. Indeed, it
appears likely, from data presented by the latter investigators,
that the solubilization methods employed preferentially extract
occupied T3-binding sites; Furthermore, Seelig et al. (60) have
recently demonstrated that binding ofT3 to solubilized hepatic
nuclear receptors at 0-40C does not follow a reversible bimolecular process, thereby making Scatchard analysis of such
data invalid. Methodologicproblems inherent to the study of
salt-solubilized receptors are thus a possible explanation for
the descrepancies noted above.
Pituitary 5'-deiodinase activity in fasted animals has been
reported to be unchanged (19, 20) or decreased (21, 22).
Previous investigators, however, by using a single relatively
high concentration of T4( 1 gM) during in vitro assay, have
not been able to distinguish between high Km (typeI) and low
Km (type II) 5'-deiodinase activity. The kinetic data presented
herein clearly demonstrate that fasting is accompanied by a
significant decrease in Vmax for the low Km 5'-deiodinase

pathway with no change in Km. This finding is in sharp
contrast to the marked elevations in low Km 5'-deiodinase
activity noted in hypothyroid animals and suggests that factors
in addition to peripheral thyroid hormone levels are involved
in regulating this physiologically important enzymatic process.
The relevance of our findings in whole pituitary homogenates to the subset of TSH-producing cells is at present
uncertain. Nevertheless, our data demonstrate that, in the
fasting state, alterations occur in thyroid hormone economy
in the pituitary, which serve to maintain relatively normal
amounts of nuclear receptor bound T3 and may result in an
actual increase in receptor occupancy. We hypothesize that
this mechanism may be responsible, at least in part, for the
observed suppression of TSH secretion that accompanies shortterm starvation in the rat.
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